CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
27 hedge funds and large institutions have $12.7M invested in Cymabay Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
4
Increased
4
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$33K |
| 2 |
2
Goldman Sachs
New York
|
$32K |
| 3 |
3
Barclays
London,
United Kingdom
|
$22K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.19M |
| 5 |
5
Morgan Stanley
New York
|
$3K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $1K | 415 | +339 | +446% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $1K | 387 | +387 | New |
|
|
UCFA
28
United Capital Financial Advisors
Irving,
Texas
| – | – | -25,920 | Closed |
|
29
JPMorgan Chase & Co
New York
| – | – | -100 | Closed |
|
30
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -68 | Closed |
|